Mark and his group have consistently provided exceptional deliverables in a timely and cost effective manner.
Innovation managers can often be challenged by a large supply of concepts and insufficient bandwidth to assess and prioritize. This is especially the case with academic technology transfer offices. A structured, objective approach can be aligned with organizational values, to identify the most attractive innovations, help accelerate opportunities and provide communication back to the original innovators.
AlvaMed provides a structured multi-attribute value analysis approach that considers reimbursement, clinical data needs, regulatory pathway, market size, reimbursement, development investments and risk.
Structure innovation submission form.
Collect consistent information from the innovators for each innovation.
Understand the innovation group’s mission to identify an assessment approach that aligns with that mission.
Build on the initial data by meeting with the original innovator to fully understand the concept and its status of development. Bring in the expertise to identify the regulatory pathway, reimbursement, clinical, and engineering risks and investments.
Apply a multi-attribute value analysis to the portfolio in order to identify the top concepts.
Provide feedback on the approach to the inventors, celebrate successes and inform the inventors on the key criteria that promote the commercial success of an innovation.
Mark and his group have consistently provided exceptional deliverables in a timely and cost effective manner.
MedTech Client
Mark Cox has more than 30 years experience in assessing early stage innovations.
